WOOF stock falls after profit beat as analysts stay cautious

WOOF stock is giving back part of its recent earnings-driven gains, even after Petco Health and Wellness Company delivered a strong Q2 2026 profit beat and raised its full-year EBITDA outlook.

Petco Health and Wellness Company (ISIN US7167441077) WOOF stock is under pressure again on September 4, 2026, trading around 2.52 dollars after recent post-earnings gains as investors digest a strong profit beat alongside cautious analyst views.

Profit beat lifts margins but sales stay flat

According to a detailed Q2 CY2026 analysis of Petco, the company generated revenue of 1.49 billion dollars in the second quarter of calendar 2026, essentially flat year on year but in line with Wall Street expectations of 1.49 billion dollars.

In the same Q2 CY2026 period, Petco reported adjusted earnings per share of 0.15 dollars, beating analyst consensus of 0.07 dollars by 0.08 dollars and signaling that profitability outpaced the lack of top line growth.

The company also delivered adjusted EBITDA of 122.2 million dollars in Q2 CY2026, compared with analyst expectations of 110.2 million dollars, corresponding to an EBITDA margin of 8.2 percent and a 10.9 percent beat versus the Street estimate.

Guidance and turnaround narrative in focus

Looking ahead, Petco expects Q3 CY2026 revenue of around 1.47 billion dollars at the midpoint of its guidance range, which the same Q2 earnings review notes is roughly in line with prevailing analyst forecasts.

For the full year, Petco has guided to EBITDA of approximately 422.5 million dollars at the midpoint, a level that aligns with analyst expectations and serves as a key reference point for investors assessing the strength and durability of the turnaround.

A separate report on recent trading points out that Petco shares traded at about 2.70 dollars shortly after the Q2 CY2026 earnings release, up from 2.63 dollars just before the numbers came out, highlighting that the profit beat initially triggered a modest positive market reaction before the latest pullback.

Analyst sentiment remains restrained

Despite the stronger Q2 CY2026 profitability, analyst sentiment on WOOF stock is still cautious. According to a fresh analyst overview compiled by TipRanks on September 4, 2026, Bank of America Securities reiterated a Sell rating on Petco Health and Wellness Company and set a price target of 3.00 dollars.

The same TipRanks data set shows that Petco currently carries an overall analyst consensus rating of Hold, with a consensus price target of 3.54 dollars, underscoring that the Street sees some upside from the current share price but is far from uniformly positive.

In parallel, a summary of recent overseas coverage indicates that other institutions such as BNP Paribas have also maintained an underperform stance on Petco and adjusted their price targets, reinforcing the view that the turnaround story, while supported by the latest margin improvement, is not yet convincing enough to shift the broader rating profile.

Pet services and products underpin growth

Petco Health and Wellness Company operates a nationwide network of pet care centers and digital platforms focused on pet supplies, services and health offerings, with recurring revenue streams from food, grooming and veterinary services playing a central role in its strategy.

In the Q2 CY2026 discussion, management and analysts highlighted that investments in loyalty programs and category expansion are designed to deepen customer relationships and support higher-margin services, a combination that helped deliver the 8.2 percent adjusted EBITDA margin in the quarter even as revenue stayed flat at 1.49 billion dollars.

WOOF stock consolidates after volatile earnings reaction

Market data referenced in recent commentary shows that WOOF stock traded around 2.63 dollars immediately before the Q2 CY2026 results and moved to approximately 2.70 dollars right after the release, while a subsequent Simply Wall St snapshot on September 4, 2026, cited a level near 2.52 dollars, implying that the share price has slipped by about 6.7 percent from the brief post-earnings peak.

For investors, the key tension is that Petco has demonstrated it can beat profit expectations, with Q2 CY2026 adjusted EPS of 0.15 dollars coming in 114 percent above the 0.07 dollar consensus and adjusted EBITDA of 122.2 million dollars exceeding forecasts by about 12.0 million dollars, yet the flat revenue trajectory and cautious analyst ratings keep WOOF stock trading in the low single-digit dollar range rather than reflecting a fully priced-in turnaround.

Petco Health and Wellness Company key data

• Company: Petco Health and Wellness Company, Inc.
• ISIN: US7167441077
• Ticker: WOOF
• Trading venue: NASDAQ
• Price (as of September 4, 2026): 2.52 USD
• Market capitalization: 767,000,000 USD (as of September 4, 2026)
• Sector / Industry: Consumer Cyclical / Specialty Retail
• Index membership: None of the major headline indices